Relay Therapeutics (RLAY) Revenue (2021 - 2026)
Relay Therapeutics (RLAY) reported Revenue of $3.0 million for Q1 2026, down 60.93% year-over-year from $7.7 million in Q1 2025, and down 57.14% on a QoQ basis from $7.0 million in Q4 2025.
Relay Therapeutics (RLAY) has 6 years of Revenue data on file, last reported at $3.0 million in Q1 2026.
- Quarterly Revenue fell 60.93% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.7 million (up 39.04% YoY) and the FY2025 annual result came in at $15.4 million, up 53.44% from the prior year.
- Revenue slipped to $3.0 million in Q1 2026 per RLAY's latest filing, from $7.0 million in the prior quarter.
- Across five years, Revenue topped out at $25.2 million in Q3 2023 and bottomed at -$1000.0 in Q4 2023.
- The 5-year median for Revenue is $419000.0 (2022), against an average of $4.3 million.
- Peak annual rise in Revenue reached 7226.16% in 2023, while the deepest fall reached 100.4% in 2023.
- Tracing RLAY's Revenue over 5 years: stood at $253000.0 in 2022, then tumbled by 100.4% to -$1000.0 in 2023, then soared by 1000800.0% to $10.0 million in 2024, then sank by 30.05% to $7.0 million in 2025, then slumped by 57.14% to $3.0 million in 2026.
- Per Business Quant, the three latest RLAY Revenue figures stand at $3.0 million (Q1 2026), $7.0 million (Q4 2025), and $677000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Relay Therapeutics | 2.53 Bn | 2.53 Bn | - | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Jun 30, 2025 | 677,000.00 |
| Mar 31, 2025 | 7.68 Mn |
| Mar 31, 2024 | 10.01 Mn |
| Dec 31, 2023 | -1,000.00 |
| Sep 30, 2023 | 25.20 Mn |
| Jun 30, 2023 | 119,000.00 |
| Mar 31, 2023 | 226,000.00 |
| Dec 31, 2022 | 253,000.00 |
| Sep 30, 2022 | 344,000.00 |
| Jun 30, 2022 | 365,000.00 |
| Mar 31, 2022 | 419,000.00 |
| Dec 31, 2021 | 567,000.00 |
| Sep 30, 2021 | 666,000.00 |
| Jun 30, 2021 | 844,000.00 |
| Mar 31, 2021 | 952,000.00 |